158 related articles for article (PubMed ID: 23755879)
1. [Reply].
Barrellier MT
J Mal Vasc; 2013 Jul; 38(4):282. PubMed ID: 23755879
[No Abstract] [Full Text] [Related]
2. [Regarding: Benefit/risk ratio analysis from a possible anticoagulation of asymptomatic deep venous thrombosis in major orthopedic surgery].
Laroche JP
J Mal Vasc; 2013 Jul; 38(4):280-1. PubMed ID: 23731505
[No Abstract] [Full Text] [Related]
3. [Benefit/risk ratio analysis from a possible anticoagulation of asymptomatic deep venous thrombosis in major orthopedic surgery].
Barrellier MT; Samama CM
J Mal Vasc; 2013 May; 38(3):178-84. PubMed ID: 23415379
[TBL] [Abstract][Full Text] [Related]
4. Prevention of venous thromboembolism.
Geerts W; Ray JG; Colwell CW; Bergqvist D; Pineo GF; Lassen MR; Heit JA
Chest; 2005 Nov; 128(5):3775-6. PubMed ID: 16304350
[No Abstract] [Full Text] [Related]
5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with ximelagatran in orthopaedic surgery.
Eriksson B
Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625
[TBL] [Abstract][Full Text] [Related]
7. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
Am J Manag Care; 2000 Nov; 6(20 Suppl):S1024-5. PubMed ID: 11484301
[No Abstract] [Full Text] [Related]
9. Venous thromboembolism debate in joint arthroplasty.
Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
[No Abstract] [Full Text] [Related]
10. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
11. Orthopaedic surgery as a model for drug development in thrombosis.
Dahl OE
Drugs; 2004; 64 Suppl 1():17-25. PubMed ID: 15586624
[TBL] [Abstract][Full Text] [Related]
12. Venous thrombosis prophylaxis with low-molecular-weight heparin in hip and knee arthroplasty.
Colwell CW
Instr Course Lect; 2002; 51():487-9. PubMed ID: 12064138
[No Abstract] [Full Text] [Related]
13. Prophylaxis against venous thromboembolism after surgery for cancer.
Moulias S; Bouchon JP; Meaume S
N Engl J Med; 2002 Jul; 347(3):220; author reply 220. PubMed ID: 12124417
[No Abstract] [Full Text] [Related]
14. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
[TBL] [Abstract][Full Text] [Related]
15. [Reflexions on the most appropriate approach with low-weight heparins for antithrombotic prophylaxis in hip and knee arthroplasty].
Iturbe Hernández T; de Miguel Olmeda R; Cornudella Lacasa R; Gutiérrez Martín M
An Med Interna; 2001 Jan; 18(1):45-6. PubMed ID: 11387846
[No Abstract] [Full Text] [Related]
16. Prophylactic low-dose aspirin therapy in patients having hip-fracture surgery or elective arthroplasty.
Grace DL
J Bone Joint Surg Am; 2001 Aug; 83(8):1277-8. PubMed ID: 11507140
[No Abstract] [Full Text] [Related]
17. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of venous thromboembolism in orthopedic surgery and traumatology].
Agnelli G; Cimminiello C
Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706
[No Abstract] [Full Text] [Related]
19. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism.
Committee on Practice Bulletins--Gynecology, American College of Obstetricians and Gynecologists
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):429-40. PubMed ID: 17666620
[No Abstract] [Full Text] [Related]
20. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
Squizzato A; Lussana F; Cattaneo M
Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
